Search Articles — Sudonull

https://sudonull.com/ibm-launches-133-qubit-quantum-computer-in-india

How IBM is building a quantum ecosystem in Asia: 133-qubit processor, Quantum Valley, and market preparation. Find out who will benefit from India's quantum leap.

https://sudonull.com/2-nm-chip-ibm-northstar-optical-interconnects-and-the-future

IBM announced the 2-nm NorthStar chip with 12 Tbit/s optical interconnects, 70% more energy efficient than copper. Analysis of implications for Nvidia, Intel, and the market. Read details.

https://sudonull.com/ibm-100-billion-in-quantum-computing-trap-or-breakthrough

Analysis of IBM's investments in Anduron quantum chips. Scaling issues, cooling, and the real cost of the quantum race. Read more.

https://sudonull.com/mit-ibm-computing-lab-hybrid-ai-and-quantum-computing

MIT and IBM have opened the Computing Research Lab to create hybrid AI and quantum computing systems. Learn about new approaches to forecasting, biology, and materials science.

https://sudonull.com/quantum-memory-on-mechanical-resonators-breakthrough-by-eth-zurich-and-ibm

European scientists have created quantum memory on HBAR with a lifetime of up to 1 ms. The architecture of a mechanical quantum computer is ready. Read analysis and forecasts.

https://ymaho.com/ibm-shares-surged-12-4-1-billion-from-us-authorities-and-quantum-breakthrough

IBM received $1 billion from the US government for quantum computing, shares rose 12.4%. We analyze the deal terms, hidden risks, and forecast. Read details.

Mar 7, 2026 ·

https://www.nature.com/articles/s41409-026-02817-0

Mar 7, 2026 · Chronic graft - versus - host disease (cGVHD) remains the leading cause of late morbidity and non-relapse mortality after allogeneic hematopoietic cell transplantation, despite major advances in ...

“Is this the GVHD?” A qualitative exploration of quality of ...

https://pmc.ncbi.nlm.nih.gov/articles/PMC7791741/

Introduction Graft - versus - host disease (GVHD) is a major complication of haematopoietic stem cell transplantation (HSCT), and a cause of significant morbidity and mortality in this patient group. GVHD is a systemic disease , able to cause pleiotropic effects in most organ systems of the body occurring at any time post-transplant [1, 2].

British Journal of Haematology | Wiley Online Library

https://onlinelibrary.wiley.com/doi/10.1111/bjh.70877

Nov 1, 2026 · Summary Acute graft - versus - host disease (aGVHD) remains a major complication following allogeneic haematopoietic stem cell transplantation (allo-HSCT), representing a leading cause of non-relapse mortality (NRM) and significant morbidity despite decades of intensive research.

National Bone Marrow Transplant LINK (nbmtLINK) | Bone Marrow ...

https://www.nbmtlink.org/

Our NEW season focuses on Chronic Graft vs . Host Disease , You’ll hear from survivors, clinicians, and more. They will share their experiences, advice, coping mechanisms, updates and tips, so you can enjoy life to the fullest, even while battling GvHD.

Mar 14, 2005 ·

https://www.health.am/conditions/graft-versus-host-disease

Mar 14, 2005 · Key points Graft - versus - host - disease is a condition that can occur following bone marrow transplant. Bone marrow transplants are performed in specialized hospitals to treat and potentially cure certain types of leukemia or other cancers that have invaded the bone marrow. Symptoms usually begin within 2 months after transplantation. Treatment consists of suppressing the immune response, but ...

Oct 6, 2026 ·

https://www.uptodate.com/contents/treatment-of-acute-graft-versus-host-disease

Oct 6, 2026 · Comprehensive guide to treating acute graft - versus - host disease with evidence-based approaches and management strategies for healthcare professionals.